Best Practices for Genomic Assay Testing in Early-Stage Breast Cancer: Clinical and Medicolegal Perspectives.
1 Evelyn Lauder Breast Center, Memorial Sloan-Kettering Cancer Center , New York, New York.
Andrew D
AD
Seidman
2 Portland Veteran Affairs Hospital , Portland, Oregon.
Darius K
DK
Amjadi
3 Compass Oncology , Portland, Oregon.
Tammy
T
De La Melena
4 Quest Diagnostics , Las Vegas, Nevada.
Darren
D
Wheeler
D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics; D055088:Early Detection of Cancer; D005260:Female; D005826:Genetics, Medical / Q000331:legislation & jurisprudence*; D023281:Genomics / Q000331:legislation & jurisprudence*; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics; D011960:Receptors, Estrogen / Q000235:genetics
D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; C508053:ERBB2 protein, human
J Clin Oncol. 2013 Aug 1;31(22):2783-90
23816962
J Natl Compr Canc Netw. 2016 Mar;14 (3):324-54
26957618
J Natl Cancer Inst. 2009 Nov 4;101(21):1446-52
19815849
JAMA Oncol. 2016 Nov 1;2(11):1477-1486
27367583
Adv Ther. 2015 Dec;32(12):1237-47
26610383
J Clin Oncol. 2016 Apr 1;34(10 ):1134-50
26858339
J Clin Oncol. 2006 Aug 10;24(23):3726-34
16720680
Lancet Oncol. 2010 Jan;11(1):55-65
20005174
N Engl J Med. 2015 Nov 19;373(21):2005-14
26412349